African Evaluation Database

9120 records found

Source	Electronic ID	Title	Authors	Publication Year	Source Title▲	Volume	Issue	DOI	Affiliations	Authors with Affiliations	Abstract	Author Keywords	Index Keywords	Funding Details
Scopus	2-s2.0-84946574725	Hepatitis B virus infection in northern Uganda: Impact of pentavalent hepatitis B vaccination	Teshale E.H., Kamili S., Drobeniuc J., Denniston M., Bakamutamaho B., Downing R.	2015	Vaccine	33	46	10.1016/j.vaccine.2015.09.058	Division of Viral Hepatitis, CDC, Atlanta, United States; Uganda Virus Research Institute, Entebb...	Teshale, E.H., Division of Viral Hepatitis, CDC, Atlanta, United States; Kamili, S., Division of ...	Chronic hepatitis B virus infection (CHBI) is effectively prevented by vaccination starting at bi...	Birth-dose; Hepatitis B virus; Mother-to-infant transmission; Pentavalent vaccine; Prevalence	hepatitis B vaccine; adult; age distribution; Article; child; child health care; hepatitis B; hum...	None	View
Scopus	2-s2.0-84880723820	Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness ...	Izurieta H.S., Zuber P., Bonhoeffer J., Chen R.T., Sankohg O., Laserson K.F., Sturkenboom M., Lou...	2013	Vaccine	31	35	10.1016/j.vaccine.2013.05.027	Food and Drug Administration (FDA), MD, United States; World Health Organization, Geneva, Switzer...	Izurieta, H.S., Food and Drug Administration (FDA), MD, United States; Zuber, P., World Health Or...	With the advent of new vaccines targeted to highly endemic diseases in low- and middle-income cou...	Adverse events; Benefit-risk; Effectiveness; Safety; Vaccine	Rotavirus vaccine; vaccine; article; Brazil; clinical evaluation; communicable disease; demograph...	Wellcome Trust	View
Scopus	2-s2.0-84904400786	Evaluation of economic costs of a measles outbreak and outbreak response activities in Keffa Zone...	Wallace A.S., Masresha B.G., Grant G., Goodson J.L., Birhane H., Abraham M., Endailalu T.B., Leta...	2014	Vaccine	32	35	10.1016/j.vaccine.2014.06.035	Global Immunization Division, Centers for Disease Control and Prevention, 1600 Clifton Road, MS-E...	Wallace, A.S., Global Immunization Division, Centers for Disease Control and Prevention, 1600 Cli...	Objective: To estimate the economic impact of a measles outbreak and response activities that occ...	Economic; Measles; Outbreak	cotrimoxazole; measles vaccine; oral rehydration solution; retinol; tetracycline; adolescent; art...	None	View
Scopus	2-s2.0-84916221953	Monitoring coverage of fully immunized children	Tsega A., Daniel F., Steinglass R.	2014	Vaccine	32	52	10.1016/j.vaccine.2014.10.057	Maternal and Child Health Integrated Program (MCHIP), 1776 Massachusetts Ave, Suite 300, NW, Wash...	Tsega, A., Maternal and Child Health Integrated Program (MCHIP), 1776 Massachusetts Ave, Suite 30...	Immunization programs monitor 3rd dose of DPT-containing vaccine coverage as a principal indicato...	Fully immunized child; Immunization; National/global immunization/vaccination indicator; Vaccination	diphtheria pertussis tetanus vaccine; Article; child; East African; human; immunization; monitori...	None	View
Scopus	2-s2.0-84903461899	The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing ...	Idoko O.T., Okolo S.N., Plikaytis B., Akinsola A., Viviani S., Borrow R., Carlone G., Findlow H.,...	2014	Vaccine	32	33	10.1016/j.vaccine.2014.04.052	Medical Research Council Unit, P.O. Box 273, Gambia; Jos University Teaching Hospital, P.M.B. 208...	Idoko, O.T., Medical Research Council Unit, P.O. Box 273, Gambia; Okolo, S.N., Jos University Tea...	Major epidemics of serogroup A meningococcal meningitis continue to affect the African meningitis...	Antibody; Conjugate vaccine; Immune response; Meningococcal A; Pre-existing	immunoglobulin G; Meningococcus vaccine; polysaccharide vaccine; bacterium antibody; immunoglobul...	None	View
Scopus	2-s2.0-34548550433	Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda	Muganga N., Uwimana J., Fidele N., Gahimbare L., Gessner B.D., Mueller J.E., Mhlanga B.R., Katsan...	2007	Vaccine	25	None	10.1016/j.vaccine.2007.06.032	Ministry of Health, Expanded Programme on Immunization, Kigali, Rwanda; Centre Hospitalier Univer...	Muganga, N., Centre Hospitalier Universitaire de Kigali, Rwanda; Uwimana, J., Centre Hospitalier ...	Rwanda introduced Haemophilus influenzae type b (Hib) conjugate vaccine in January 2002 and simul...	Epidemiology; Haemophilus influenzae; Meningitis; Rwanda; Vaccine; Vaccine effectiveness; Vaccine...	antiretrovirus agent; diphtheria pertussis tetanus vaccine; Haemophilus influenzae type b vaccine...	None	View
Scopus	2-s2.0-33747588525	The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in...	Daza P., Banda R., Misoya K., Katsulukuta A., Gessner B.D., Katsande R., Mhlanga B.R., Mueller J....	2006	Vaccine	24	None	10.1016/j.vaccine.2006.05.076	Mzuzu Central Hospital, Mzuzu, Malawi; World Health Organization, Lilongwe, Malawi; Queen Elizabe...	Daza, P., Mzuzu Central Hospital, Mzuzu, Malawi; Banda, R., World Health Organization, Lilongwe, ...	Malawi has extreme poverty and a high-human immunodeficiency virus (HIV) prevalence. Following Ha...	Haemophilus influenzae; Malawi; Vaccine effectiveness	amoxicillin; chloramphenicol; diphtheria pertussis tetanus vaccine; Haemophilus influenzae type b...	None	View
Scopus	2-s2.0-84930606468	Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains agai...	Gari G., Abie G., Gizaw D., Wubete A., Kidane M., Asgedom H., Bayissa B., Ayelet G., Oura C.A.L.,...	2015	Vaccine	33	28	10.1016/j.vaccine.2015.01.035	National Animal Health Diagnostic and Investigation Center (NAHDIC), Sebeta, Ethiopia; National V...	Gari, G., National Animal Health Diagnostic and Investigation Center (NAHDIC), Sebeta, Ethiopia; ...	The safety, immunogenicity and efficacy of three commercially available vaccines against lumpy sk...	Cattle; Gorgangoat pox strain; Kenyan sheep and goat pox strain; Lumpy skin disease; Neethling st...	gorgan goat pox vaccine; live vaccine; lumpy skin disease virus vaccine; neethling and kenyan she...	None	View
Scopus	2-s2.0-84925969577	Economic evaluation of typhoid vaccination in a prolonged typhoid outbreak setting: The case of K...	Carias C., Walters M.S., Wefula E., Date K.A., Swerdlow D.L., Vijayaraghavan M., Mintz E.	2015	Vaccine	33	17	10.1016/j.vaccine.2015.02.027	Office of Science and Integrated Programs, Centers for Disease Control and Prevention, Atlanta, G...	Carias, C., Office of Science and Integrated Programs, Centers for Disease Control and Prevention...	Background: Vaccination has been increasingly promoted to help control epidemic and endemic typho...	Cost-effectiveness; Typhoid; Typhoid vaccination; Uganda	typhoid vaccine; typhoid paratyphoid vaccine; Article; disability adjusted life year; economic ev...	None	View
Scopus	2-s2.0-77953123428	Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep	Dungu B., Louw I., Lubisi A., Hunter P., von Teichman B.F., Bouloy M.	2010	Vaccine	28	29	10.1016/j.vaccine.2010.04.085	Onderstepoort Biological Products Ltd., Private Bag X07, Onderstepoort, 0110, South Africa; ARC-O...	Dungu, B., Onderstepoort Biological Products Ltd., Private Bag X07, Onderstepoort, 0110, South Af...	The efficacy and safety of the naturally attenuated Rift Valley Fever (RVF) Clone 13 vaccine were...	Rift Valley Fever; Sheep; Vaccine	Rift Valley fever clone 13 vaccine; unclassified drug; virus vaccine; animal experiment; animal m...	None	View
Scopus	2-s2.0-15044364080	Evaluation of the xerovac process for the preparation of heat tolerant contagious bovine pleuropn...	Litamoi J.K., Ayelet G., Rweyemamu M.M.	2005	Vaccine	23	20	10.1016/j.vaccine.2004.11.031	PANVAC, P.O. Box 1746, Debre Zeit, Ethiopia; National Veterinary Institute, P.O. Box 19, Debre-Ze...	Litamoi, J.K., PANVAC, P.O. Box 1746, Debre Zeit, Ethiopia; Ayelet, G., National Veterinary Insti...	The study was conducted with the aim of evaluating the xerovac process as a method for preparing ...	CBPP vaccine; Heat tolerance; Lyophilization; Xerovac	bacterial vaccine; chitosan; contagious bovine pleuropneumonia vaccine; trehalose; unclassified d...	None	View
Scopus	2-s2.0-50549102649	Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals	von Teichman B.F., Smit T.K.	2008	Vaccine	26	39	10.1016/j.vaccine.2008.07.037	Research and Development Virology, Onderstepoort Biological Products Ltd., Private Bag X07, Onder...	von Teichman, B.F., Research and Development Virology, Onderstepoort Biological Products Ltd., Pr...	Background: The polyvalent African Horsesickness (AHS) attenuated live vaccine (ALV) produced by ...	African Horsesickness; Reassortant; Reassortment; Reversion to virulence; Vaccination	African horse sickness vaccine; complementary DNA; live vaccine; unclassified drug; virus RNA; Af...	None	View
Scopus	2-s2.0-79954867583	Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose	Klugman K.P., Madhi S.A., Adegbola R.A., Cutts F., Greenwood B., Hausdorff W.P.	2011	Vaccine	29	18	10.1016/j.vaccine.2011.02.089	Respiratory and Meningeal Pathogens Research Unit, Medical Research Council, University of Witwat...	Klugman, K.P., Respiratory and Meningeal Pathogens Research Unit, Medical Research Council, Unive...	Protection against serotype 1 could not be demonstrated in two randomized trials of 9 valent pneu...	Conjugate pneumococcal vaccine; Pneumococcus; Serotype 1	Pneumococcus vaccine; article; booster dose; drug dose regimen; Gambia; human; infancy; invasive ...	None	View
Scopus	2-s2.0-84867018746	Stability of a formalin-inactivated Rift Valley fever vaccine: Evaluation of a vaccination campai...	Lagerqvist N., Moiane B., Bucht G., Fafetine J., Paweska J.T., Lundkvist T., Falk K.I.	2012	Vaccine	30	46	10.1016/j.vaccine.2012.08.052	Swedish Institute for Communicable Disease Control, SE-171 82 Solna, Sweden; Department of Microb...	Lagerqvist, N., Swedish Institute for Communicable Disease Control, SE-171 82 Solna, Sweden, Depa...	In Africa and the Arabian Peninsula, outbreaks of Rift Valley fever (RVF) are characterized by ab...	Bovine; Formalin-inactivated vaccine; Mozambique; Rift Valley fever; Virus	formaldehyde; inactivated vaccine; neutralizing antibody; rift valley fever vaccine; unclassified...	None	View
None	None	Impact of malaria and helminth infections on immunogenicity of the human papillomavirus-16/18 AS0...	Brown J., Baisley K., Kavishe B., Changalucha J., Andreasen A., Mayaud P., Gumodoka B., Kapiga S....	2014	Vaccine	32	5	10.1016/j.vaccine.2013.11.061	University of California, San Francisco, Department of Epidemiology and Biostatistics, San Franci...	Brown, J., University of California, San Francisco, Department of Epidemiology and Biostatistics,...	Background: Endemic malaria and helminth infections in sub-Saharan Africa can act as immunologica...	Helminth; HPV; Human papillomavirus; Immunogenicity; Malaria; Parasitic infection; Sub-Saharan Af...	placebo; virus antibody; Wart virus vaccine; adolescent; adult; antibody response; antibody titer...	None	View
Scopus	2-s2.0-34247381211	Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies	Weyer J., Rupprecht C.E., Mans J., Viljoen G.J., Nel L.H.	2007	Vaccine	25	21	10.1016/j.vaccine.2007.02.084	University of Pretoria, Department of Microbiology and Plant Pathology, Pretoria, 0002, South Afr...	Weyer, J., University of Pretoria, Department of Microbiology and Plant Pathology, Pretoria, 0002...	Modified vaccinia virus Ankara (MVA) has become a vaccine vector of choice for recombinant vaccin...	Modified vaccinia virus Ankara; Oral vaccine; Rabies vaccine	modified vaccinia virus Ankara vaccine; rabies vaccine; rabies virus glycoprotein; recombinant mo...	None	View
WoS	WOS:000345469000029	The impact of introducing new vaccines on the health system: Case studies from six low- and middl...	Burchett, Helen E. D.,Chavez, Enrique,Edengue, Jean-Marie,Gelmon, Lawrence,Griffiths, Ulla K.,Kit...	2014	VACCINE	33	49	10.1016/j.vaccine.2014.09.032	Addis Ababa University, University of London, University of Manitoba, University of Nairobi, Univ...	"Burchett, Helen E. D.: University of London","Griffiths, Ulla K.: University of London","Lagarde...	Objective: We aimed to explore the impacts of new vaccine introductions on immunization programme...	"HEALTH SYSTEMS","immunisation programmes",INTRODUCTIONS,"new vaccines",AFRICA,"ELIMINATION ACTIV...	None	None	View
Scopus	2-s2.0-84915784151	Economic evaluation of a cluster randomized trial of interventions to improve health workers' pra...	Mangham-Jefferies L., Wiseman V., Achonduh O.A., Drake T.L., Cundill B., Onwujekwe O., Mbacham W.	2014	Value in Health	17	8	10.1016/j.jval.2014.07.010	Department of Global Health and Development, London School of Hygiene and Tropical Medicine, 15-1...	Mangham-Jefferies, L., Department of Global Health and Development, London School of Hygiene and ...	Background Malaria rapid diagnostic tests (RDTs) are a valid alternative to malaria testing with ...	Cameroon cluster-randomized trial; cost-effectiveness analysis; health worker training; malaria p...	antimalarial agent; artemisinin; adolescent; adult; Article; Cameroon; child; controlled study; c...	ACT, Arts and Culture Trust	View
Scopus	2-s2.0-84884137465	Performance assessment of ga district mutual health insurance scheme, greater accra region, Ghana	Nsiah-Boateng E., Aikins M.	2013	Value in Health Regional Issues	2	2	10.1016/j.vhri.2013.06.005	Claims Department, National Health Insurance Scheme, Ashiedu Keteke Submetro Office, Accra, Ghana...	Nsiah-Boateng, E., Claims Department, National Health Insurance Scheme, Ashiedu Keteke Submetro O...	Objective: This study assessed performance of the Ga District Mutual Health Insurance Scheme over...	Claims settlements; Ghana; Membership coverage; National Health Insurance Scheme.	article; capitation fee; financial management; Ghana; health care cost; health care delivery; hea...	None	View
Scopus	2-s2.0-84884131310	The methodological challenges for the estimation of quality of life in children for use in econom...	Mabugu T., Revill P., van den Berg B.	2013	Value in Health Regional Issues	2	2	10.1016/j.vhri.2013.07.005	Clinical Research Centre, University of Zimbabwe, Harare, Zimbabwe; Centre for Health Economics, ...	Mabugu, T., Clinical Research Centre, University of Zimbabwe, Harare, Zimbabwe; Revill, P., Centr...	Objectives: The assessment of quality of life (QOL) in children has been underresearched in high-...	Children; HIV/AIDS; Low-income; Quality of life	antiretrovirus agent; cotrimoxazole; academic achievement; acquired immune deficiency syndrome; a...	None	View

Export:CSV CSV (hidden cols)HTML JSON TSV (Spreadsheets)TSV (Spreadsheets, hidden cols)XML